Rabeprazole sodium and Demyelination - a phase IV clinical study of FDA data

Summary:

Demyelination is reported as a side effect among people who take Rabeprazole sodium (rabeprazole sodium), especially for people who are female, 60+ old, have been taking the drug for < 1 month also take Methotrexate, and have Rheumatoid arthritis.

The phase IV clinical study analyzes which people have Demyelination when taking Rabeprazole sodium. It is created by eHealthMe based on reports of 15,623 people who have side effects when taking Rabeprazole sodium from the FDA, and is updated regularly.

What is Rabeprazole sodium?

Rabeprazole sodium has active ingredients of rabeprazole sodium. It is often used in gastroesophageal reflux disease. eHealthMe is studying from 15,786 Rabeprazole sodium users. Check the latest studies of Rabeprazole sodium.

What is Demyelination?

Demyelination (loss of the myelin covering of some nerve fibres resulting in their impaired function) is found to be associated with 458 drugs and 670 conditions by eHealthMe. Check the latest studies of Demyelination.

eHealthMe: drug outcomes in the real world

eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.

On Aug, 30, 2026

15,623 people reported to have side effects when taking Rabeprazole sodium.
Among them, 11 people (0.07%) have Demyelination.

Could Rabeprazole sodium cause Demyelination?

Among these 11 people:

How long have people been on Rabeprazole sodium when they have Demyelination? *

What is the gender of people who have Demyelination when taking Rabeprazole sodium? *

female: 57.14 %
male: 42.86 %

What is the age of people who have Demyelination when taking Rabeprazole sodium? *

What are other drugs people take besides Rabeprazole sodium? *

Methotrexate: 8 people, 72.73%
Folic Acid: 5 people, 45.45%
Hydrochlorothiazide: 4 people, 36.36%
Actemra: 4 people, 36.36%
Amlodipine Besylate: 4 people, 36.36%
Aubagio: 4 people, 36.36%
Citalopram Hydrobromide: 4 people, 36.36%
Curcumin: 4 people, 36.36%
Diphenhydramine Hydrochloride: 4 people, 36.36%
Ibuprofen: 4 people, 36.36%

What are other side effects people have besides Demyelination? *

Diarrhea: 6 people, 54.55%
Nausea And Vomiting: 6 people, 54.55%
Weight Increased: 4 people, 36.36%
Restless Leg Syndrome (a powerful urge to move your legs): 4 people, 36.36%
Blood Pressure Systolic Increased: 4 people, 36.36%
Fever: 4 people, 36.36%
Gastrointestinal Disorder (functional problems of gastrointestinal tract): 4 people, 36.36%
Weight Decreased: 4 people, 36.36%
Indigestion: 4 people, 36.36%
Multiple Sclerosis (a nervous system disease that affects your brain and spinal cord. it damages the myelin sheath): 4 people, 36.36%

What are the existing conditions these people have? *

Rheumatoid Arthritis (a chronic progressive disease causing inflammation in the joints): 9 people, 81.82%
Depression: 4 people, 36.36%
Polycystic Ovary Disease (cysts in the ovaries that occurs when the follicle stops developing): 3 people, 27.27%
Immunodeficiency Disorders: 2 people, 18.18%
Stomatitis (inflammation of mucous membrane of mouth): 1 person, 9.09%
Spinal Column Stenosis (narrowing of spinal column): 1 person, 9.09%
Sinusitis (inflammation of sinus): 1 person, 9.09%
Reflux Oesophagitis (an oesophageal mucosal injury that occurs of gastric contents into the oesophagus): 1 person, 9.09%
Osteoporosis (bones weak and more likely to break): 1 person, 9.09%
Neurogenic Bladder (the normal function of the bladder is to store and empty urine in a coordinated, controlled fashion): 1 person, 9.09%

* Approximation only. Some reports may have incomplete information.

Do you take Rabeprazole sodium and have Demyelination?

- Check whether Demyelination is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Rabeprazole sodium:

Rabeprazole sodium (15,786 reports)

Demyelination treatments and more:

Demyelination (5,739 reports)

Browse all side effects of Rabeprazole sodium:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Demyelination:

Demyelination (458 drugs)

Browse all the conditions that are associated with Demyelination:

Demyelination (670 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on rabeprazole sodium (the active ingredients of Rabeprazole sodium) and Rabeprazole sodium (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.